Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling.
Alshaer MH, Williams R, Mousa MJ, Alexander KM, Maguigan KL, Manigaba K, Maranchick N, Shoulders BR, Felton TW, Mathew SK, Peloquin CA. Alshaer MH, et al. Crit Care Explor. 2023 Oct 27;5(11):e0993. doi: 10.1097/CCE.0000000000000993. eCollection 2023 Nov. Crit Care Explor. 2023. PMID: 38304706 Free PMC article.
Another trial for the TARGET trial.
Alshaer MH, Peloquin CA. Alshaer MH, et al. Intensive Care Med. 2022 Jun;48(6):774-775. doi: 10.1007/s00134-022-06654-9. Epub 2022 Mar 1. Intensive Care Med. 2022. PMID: 35230463 No abstract available.
Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia.
Alshaer MH, Maranchick N, Bai C, Maguigan KL, Shoulders B, Felton TW, Mathew SK, Mardini MT, Peloquin CA. Alshaer MH, et al. Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0056322. doi: 10.1128/aac.00563-22. Epub 2022 Jun 14. Antimicrob Agents Chemother. 2022. PMID: 35699444 Free PMC article.
Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity.
Venugopalan V, Casaus D, Kainz L, Slaton CN, Hurst N, Bruzzone M, Hu C, Sword G, Cherabuddi K, Iovine N, Liu J, Scheetz MH, Rhodes N, Maranchick N, Peloquin CA, Klinker K, Alshaer MH. Venugopalan V, et al. Among authors: alshaer mh. Pharmacotherapy. 2023 Jan;43(1):6-14. doi: 10.1002/phar.2744. Epub 2022 Dec 2. Pharmacotherapy. 2023. PMID: 36401796
75 results